Ensysce Biosciences, Inc. (ENSC) Discusses Acquisition of Cy Biopharma and Private Placement Financing Prepared Remarks Transcript
PresentationGreetings, and welcome to the Ensysce Biosciences, Inc. Corporate Update Call. [Operator Instructions] It is now my pleasure to introduce your host, Dr. Lynn Kirkpatrick, Chief Executive Officer. Thank you. You may begin.D. KirkpatrickPresident, CEO & Director Thank you, operator, and good morning, everyone. Thank you for joining us. We recently issued a press release outlining our acquisition of Cy Biopharma and a concurrent private placement financing. That release, along with an updated corpo ...